Odyssey Therapeutics, Inc. (NASDAQ:ODTX – Get Free Report) Director Nan (Ln) Li acquired 1,111,111 shares of the company’s stock in a transaction on Monday, May 11th. The stock was bought at an average price of $18.00 per share, for a total transaction of $19,999,998.00. Following the purchase, the director owned 3,333,516 shares in the company, valued at approximately $60,003,288. This trade represents a 50.00% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Odyssey Therapeutics Trading Up 6.3%
ODTX stock traded up $1.03 during midday trading on Monday, reaching $17.45. The company had a trading volume of 426,992 shares. Odyssey Therapeutics, Inc. has a 1 year low of $15.35 and a 1 year high of $20.30.
Read More
- Five stocks we like better than Odyssey Therapeutics
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Odyssey Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Odyssey Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
